TE
BBIO icon

Tema ETFs’s BridgeBio Pharma BBIO Stock Holding History

Tema ETFs’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Sell
76,076
-36,197
-32% -$2.54M 0.18% 101
2026
Q1 		$8.34M Buy
112,273
+28,871
+35% +$2.09M 0.56% 53
2025
Q4 		$6.38M Sell
83,402
-13,159
-14% -$864K 0.5% 62
2025
Q3 		$5.02M Sell
96,561
-27,026
-22% -$1.32M 0.42% 70
2025
Q2 		$5.34M Sell
123,587
-25,530
-17% -$929K 1.42% 18
2025
Q1 		$5.15M Buy
149,117
+7,145
+5% +$241K 1.54% 17
2024
Q4 		$3.9M Buy
+141,972
New +$3.67M 1.62% 23

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Tema ETFs's BBIO Position: Q2 2026 in Review

Tema ETFs reduced its BridgeBio Pharma (BBIO) stake by 32% in Q2 2026, selling an estimated $2.54M and leaving 76,076 shares worth $5.67M. The position accounts for 0.18% of the portfolio, ranked #101.

Tema ETFs first reported a position in BBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.34M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Tema ETFs held 76,076 shares of BridgeBio Pharma worth $5.67M as of Q2 2026.
  • Tema ETFs sold 36,197 BridgeBio Pharma shares in Q2 2026, an estimated $2.54M.
  • BridgeBio Pharma made up 0.18% of Tema ETFs's portfolio in Q2 2026, its #101 holding.
  • Tema ETFs first reported a position in BridgeBio Pharma in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's BridgeBio Pharma position peaked at $8.34M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.